PODAFEB

For 80 mg and 120 mg doses Treatment of chronic hyperuricemia in diseases accompanied by urate crystal deposition, including current or previous history of tophi and/or gouty arthritis.
For a dosage of 120 mg Treatment and prevention of hyperuricemia in adult patients undergoing chemotherapy for haematological malignancies with a moderate or high risk of tumour lysis syndrome (TLS). The medicine is indicated for adult patients.